Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Cornell Research Foundation Inc patents


Recent patent applications related to Cornell Research Foundation Inc. Cornell Research Foundation Inc is listed as an Agent/Assignee. Note: Cornell Research Foundation Inc may have other listings under different names/spellings. We're not affiliated with Cornell Research Foundation Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "C" | Cornell Research Foundation Inc-related inventors


Fagopyritol synthase genes and uses thereof

The present invention relates to an isolated dna molecule encoding a fagopyritol synthase. A method for producing a fagopyritol, an insulin mediator, an insulin mediator analogue, an insulin mediator homologue, or an insulin mediator inhibitor is also described. ... Cornell Research Foundation Inc

Modifield antibodies to prostate-specific membrane antigen and uses thereof

Modified antibodies, or antigen-binding fragments thereof, to the extracellular domain of human prostate specific membrane antigen (psma) are provided. The modified anti-psma antibodies, or antigen-binding fragments thereof, have been rendered less immunogenic compared to their unmodified counterparts to a given species, e.g., a human. ... Cornell Research Foundation Inc

Method of designing addressable array suitable for detection of nucleic acid sequence differences using ligase detection reaction

The present invention is directed to a method of designing a plurality of capture oligonucleotide probes for use on a support to which complementary oligonucleotide probes will hybridize with little mismatch, where the plural capture oligonucleotide probes have melting temperatures within a narrow range. The present invention further relates to an oligonucleotide array comprising of a support with the plurality of oligonucleotide probes immobilized on the support, a method of using the support to detect single-base changes, insertions, deletions, or translocations in a plurality of target nucleotide sequences, and a kit for such detection, which includes the support on which the oligonucleotides have been immobilized.. ... Cornell Research Foundation Inc

Methods for reducing cd36 expression

The invention provides a method for treating one or more complications of diabetes in a mammal. The method comprises administering to a mammal in need thereof an effective amount of an aromatic-cationic peptide having at least one net positive charge; a minimum of four amino acids; a maximum of about twenty amino acids; a relationship between the minimum number of net positive charges (pm) and the total number of amino acid residues (r) wherein 3 pm is the largest number that is less than or equal to r+1; and a relationship between the minimum number of aromatic groups (a) and the total number of net positive charges (pt) wherein 2a is the largest number that is less than or equal to pt+1, except that when a is 1, pt may also be 1.. ... Cornell Research Foundation Inc

Myelination of congenitally dysmyelinated forebrains using oligodendrocyte progenitor cells

One form of the present invention is directed to a method of remyelinating demyelinated axons by treating the demyelinated axons with oligodendrocyte progenitor cells under conditions which permit remyelination of the axons. Another aspect of the present invention relates to a method of treating a subject having a condition mediated by a loss of myelin or a loss of oligodendrocytes by administering to the subject oligodendrocyte progenitor cells under conditions effective to treat the condition mediated by a loss of myelin or a loss of oligodendrocytes. ... Cornell Research Foundation Inc

Modulating the production of neurons and/or oligodendrocytes from white matter progenitor cells

The present invention relates to a method of modulating production of neurons and/or oligodendrocytes from neural progenitor cells of human white matter and to a method of treating a subject for a condition modulated by underproduction of oligodendrocytes from human white matter. Both of these methods involve administering an agonist or antagonist of one or more molecules set forth in tables 1 and/or 2 to the neural progenitor cells. ... Cornell Research Foundation Inc

Methods of predicting acute rejection outcomes

A method for assessing risk of losing a transplanted organ by a patient having an episode of acute rejection of the transplanted organ is described. The method includes obtaining from the patient a cell sample from the transplanted organ or peripheral blood, determining a level of foxp3 in the cell sample, and correlating the level with the risk of loss of the transplanted organ, wherein, compared to a control level, a significantly greater level of foxp3 in the cell sample from the transplanted organ or a significantly lower level of foxp3 in the cell sample from the peripheral blood correlates with a decreased risk of loss of the transplanted organ.. ... Cornell Research Foundation Inc

Method and carrier complexes for delivering molecules to cells

The invention relates to carrier complexes and methods for delivering molecules to cells. The carrier complexes comprises a molecule and an aromatic cationic peptide in accordance with the invention. ... Cornell Research Foundation Inc

Method of treating or retarding the development of blindness

A method for treating an ocular disorder characterized by the defect or absence of a normal gene in the ocular cells of a human or animal subject involves administering to the subject by subretinal injection an effective amount of a recombinant adeno-associated virus carrying a nucleic acid sequence encoding the normal gene under the control of a promoter sequence which expresses the product of the gene in the ocular cells. The ocular cells are preferably retinal pigment epithelial (rpe) cells, and the gene is preferably an rpe-specific gene, e.g., rpe65. ... Cornell Research Foundation Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Cornell Research Foundation Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Cornell Research Foundation Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###